引用本文
  • 张莉莉,王强兄,沈亮亮,等.曲霉菌临床分离株的分子鉴定及体外抗真菌药物敏感性分析[J].同济大学学报(医学版),2018,39(1):70-75.    [点击复制]
  • ZHANG Li-li,WANG Qiang-xiong,SHEN Liang-liang,et al.Molecular identification and antifungal susceptibility in clinical isolates of Aspergillus species[J].同济大学学报(医学版),2018,39(1):70-75.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 800次   下载 1462 本文二维码信息
码上扫一扫!
曲霉菌临床分离株的分子鉴定及体外抗真菌药物敏感性分析
张莉莉,王强兄,沈亮亮,冀燕芬,邓淑文,赵敬军
0
(同济大学附属同济医院皮肤科,上海200065;上海长征医院皮肤病与真菌病研究所-上海市医学真菌重点分子生物学实验室,上海200003)
摘要:
目的 研究曲霉菌临床分离株的分子鉴定及体外抗真菌药物的敏感性。方法 采用Internal Transcribed Spacer(ITS)及β-tubulin基因部分测序对临床分离的53株经形态学鉴定为曲霉的菌株进行分子鉴定,并按照美国临床实验室标准化协会(CLSI)推荐的M38-A2微量液基稀释法测定唑类(伊曲康唑、伏立康唑、泊沙康唑),两性霉素B和棘白菌素类(米卡芬净、阿尼芬净和卡泊芬净)共7种抗真菌药物对所有菌株的最低抑菌浓度(minimum inhibitory concentration, MIC)或最低有效浓度(minimum effective concentration, MEC)。结果 53株曲霉菌包含烟曲霉复合体22株(烟曲霉21株和仑图卢斯曲霉1株),黑曲霉复合体23株(塔宾曲霉16株、黑曲霉5株和百岁兰曲霉2株)及土曲霉和黄曲霉各4株;米卡芬净、阿尼芬净、卡泊芬净、泊沙康唑、伏立康唑、伊曲康唑、两性霉素B对曲霉菌株的MIC90为0.031、0.031、0.25、0.5、0.5、1、2μg/mL。除1株烟曲霉对伊曲康唑(MIC≥16μg/mL)和伏立康唑(MIC为2μg/mL)耐药及1株仑图卢斯曲霉对两性霉素B耐药(MIC为8μg/mL)外,其余菌株对7种药物均敏感。4种曲霉复合体对7种抗真菌药物的敏感性差异有统计学意义(P<0.05)。结论 棘白菌素类药物体外抗曲霉菌活性最好,两性霉素B体外抗曲霉菌活性相对较差,唑类药物介于以上两者之间。不同种曲霉菌对不同抗真菌药物的敏感性存在差别。
关键词:  曲霉菌  抗真菌药物敏感性试验  微量液基稀释法
DOI:10.16118/j.1008-0392.2018.01.014
投稿时间:2017-05-25
基金项目:上海市自然科学基金(16ZR1432400)
Molecular identification and antifungal susceptibility in clinical isolates of Aspergillus species
ZHANG Li-li,WANG Qiang-xiong,SHEN Liang-liang,JI Yan-fen,DENG Shu-wen,ZHAO Jing-jun
(Dept. of Dermatology, Tongji Hospital, Tongji University, Shanghai 200065, China;Institute of Medical Mycology-Shanghai Key Laboratory of Mocology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China)
Abstract:
Objective To investigate the molecular identification and susceptibility to antifungal agents of clinical isolates of Aspergillus species. Methods Fifty-three clinical isolates of Aspergillus were identified to species level based on Internal Transcribed Spacer(ITS) and β-tubulin gene sequencing. The in vitro susceptibility to anidulafungin, caspofungin, micafungin, posaconazole, voriconazole, itraconazole and amphotericin B was tested by CLSI M38-A2. Results Among 53 isolates, there were 21 strains of Aspergillus fumigatus, 16 of Aspergillus tubingensis, 5 of Aspergillus niger, 4 of Aspergillus flavus, 4 of Aspergillus terreus, 2 of A. welwitschiae and 1 of A. lentulus. The MIC90 of micafungin,anidulafungin, caspofungin, posaconazole, voriconazole, itraconazole, amphotericin B were 0.031, 0.031, 0.25, 0.5, 0.5,1 and 2μg/mL.One Aspergillus fumigatus strain showed resistance to itraconazole and voriconazole. Aspergillus lentulus strain was resistant to Amphotericin B. Other strains were sensitive to 7 antifungal angents.The susceptibility of 4 species complexes to different antifungal drugs was statistically significant differences(P<0.05). Conclusion Echinocandins drugs have best antifungal activity against 5 Aspergillus species, followed by asoles and amphotericin B. Different species of Aspergillus show different patterns of antifungal susceptibility.
Key words:  Aspergillus species  antifungal susceptibility test  microdilution method

您是第5092618位访问者
版权所有《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计